Dudediligence.

Corbus Pharmaceuticals Holdings, Inc

CRBPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

18.7M

on 2026-06-30, from 10.5M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

5M10M15M20MMar2024JunSepDecMar2025JunSepDec$13.00Mar2026Jun

Newest

$300.0M

S-3 of 2026-03-11. 1 prospectus supplement filed under it since. S-3 ↗

$127.5M

Jefferies, agreement of 2026-08-07. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

5.4 quarters

$117.9M on 2026-06-30 ÷ $21.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-10-30Public offering incl. 1.02M pre-funded5,769,231$13.00$75.0M424B5 ↗